✦ LIBER ✦

Dipeptidyl peptidase-4 (DPP-4) inhibitors are favourable to Glucagon-Like Peptide-1 (GLP-1) agonists: No

✍ Scribed by Sten Madsbad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidylpeptidase-4 (DPP-4) inhibitors

✍ André J. Scheen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Cardiovascular Preventing Effects of Dip

✍ Xi-Mei Wang; Yue-Jin Yang; Yong-Jian Wu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Incretin-based treatment of type 2 diabe

✍ Carolyn F. Deacon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

The incretin system: glucagon-like pepti

✍ Daniel J Drucker; Michael A Nauck 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 320 KB

Canagliflozin (CANA) Added on to Dipepti

✍ Woo, Vincent; Wysham, Carol; Mathieu, Chantal; Desai, Mehul; Alba, Maria; Capuan 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 53 KB

Novel therapeutics for type 2 diabetes:

✍ E.J. Verspohl 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 913 KB